Latest news
Loading news…
Cullinan Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2016 101-250 employees For Profit
Cullinan Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases and cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
2
4 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $500M to $1B
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 38
- Active products
- 22
- Patents granted
- 2
- Trademarks
- 4
- Top patent class
- Organic Chemistry
- IT spend
- $390K
Company Info
- Founded
- 2016
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- News articles
- 25
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 3.8
- Trend (30d)
- 7
- Trend (90d)
- 6.3
- Last leadership hire
- Aug 7, 2025
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Cullinan Therapeutics
Loading news…
FAQs about Cullinan Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.